B K Keppler Selected Research

indazolium trans- (tetrachlorobis(1H- indazole)ruthenate (III))

1/2009	Inhibitory Effects of the Ruthenium Complex KP1019 in Models of Mammary Cancer Cell Migration and Invasion.
2/2005	Heterocyclic complexes of ruthenium(III) induce apoptosis in colorectal carcinoma cells.
1/2005	Intrinsic and acquired forms of resistance against the anticancer ruthenium compound KP1019 [indazolium trans-[tetrachlorobis(1H-indazole)ruthenate (III)] (FFC14A).
1/2003	Recent developments in the field of tumor-inhibiting metal complexes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

B K Keppler Research Topics

Disease

16	Neoplasms (Cancer) 02/2017 - 01/2000
3	Breast Neoplasms (Breast Cancer) 01/2009 - 01/2005
2	Hypersensitivity (Allergy) 02/2017 - 06/2007
2	Colorectal Neoplasms (Colorectal Cancer) 02/2017 - 02/2005
2	Neoplasm Metastasis (Metastasis) 01/2009 - 01/2003
1	Leukemia 05/2015
1	Burns 01/2005
1	Vomiting 01/2005
1	Wounds and Injuries (Trauma) 01/2005
1	Sepsis (Septicemia) 01/2005
1	Carcinoma (Carcinomatosis) 01/2003

Drug/Important Bio-Agent (IBA)

7	RutheniumIBA 01/2015 - 01/2000
4	Cisplatin (Platino)FDA LinkGeneric 02/2017 - 01/2001
4	Pharmaceutical PreparationsIBA 05/2016 - 01/2003
4	IndazolesIBA 01/2015 - 01/2000
4	indazolium trans- (tetrachlorobis(1H- indazole)ruthenate (III))IBA 01/2009 - 01/2003
3	Biological ProductsIBA 01/2017 - 01/2009
2	ProdrugsIBA 05/2016 - 01/2003
2	PlatinumIBA 05/2016 - 01/2003
2	DNA (Deoxyribonucleic Acid)IBA 08/2009 - 04/2001
2	Proteins (Proteins, Gene)FDA Link 06/2007 - 01/2005
2	Cytostatic AgentsIBA 02/2005 - 04/2001
2	LigandsIBA 08/2001 - 01/2000
2	NitrogenIBA 08/2001 - 01/2000
2	Ruthenium CompoundsIBA 04/2001 - 03/2001
2	tetrachlorobis(indazole)ruthenate(III)IBA 03/2001 - 01/2000
1	TrabectedinIBA 02/2017
1	3-aminopyridine-2-carboxaldehyde thiosemicarbazone (triapine)IBA 05/2015
1	Antineoplastic Agents (Antineoplastics)IBA 06/2007
1	LanthanumIBA 06/2007
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 06/2007
1	tris(8-quinolinolato)gallium (III)IBA 12/2005
1	SodiumIBA 02/2005
1	KP 1339IBA 02/2005
1	SaltsIBA 02/2005
1	Transferrin Receptors (Transferrin Receptor)IBA 01/2005
1	Silver Sulfadiazine (SSD)FDA LinkGeneric 01/2005
1	CeriumIBA 01/2005
1	OxalatesIBA 01/2005
1	AntiemeticsIBA 01/2005
1	Local Anti-Infective Agents (Antiseptics)IBA 01/2005
1	major vault proteinIBA 01/2005
1	cerium nitrateIBA 01/2005
1	GalliumIBA 01/2003
1	Platinum Compounds (Compounds, Platinum)IBA 01/2003
1	imidazolium- bis(imidazole)dimethylsulfoxideimidazotetrachlororuthenate(III) (NAMI-A)IBA 01/2003
1	Coordination ComplexesIBA 01/2003
1	NucleotidesIBA 08/2001
1	imidazoleIBA 03/2001
1	Carboplatin (JM8)FDA LinkGeneric 01/2001

Therapy/Procedure

1	Therapeutics 01/2015
1	Drug Therapy (Chemotherapy) 06/2007
1	Investigational Therapies (Experimental Therapy) 02/2005